MicroRNAs as potential biomarkers and therapeutic targets in age-related macular degeneration.

Cruz-Aguilar M, Groman-Lupa S, Jiménez-Martínez MC

Open source

DOI
10.3389/fopht.2023.1023782
Published
2023
Container
Frontiers in ophthalmology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fopht.2023.1023782,
  title = {MicroRNAs as potential biomarkers and therapeutic targets in age-related macular degeneration.},
  author = {Cruz-Aguilar M and Groman-Lupa S and Jiménez-Martínez MC},
  year = {2023},
  journal = {Frontiers in ophthalmology},
  doi = {10.3389/fopht.2023.1023782},
  url = {https://doi.org/10.3389/fopht.2023.1023782}
}

RIS

TY  - JOUR
TI  - MicroRNAs as potential biomarkers and therapeutic targets in age-related macular degeneration.
AU  - Cruz-Aguilar M
AU  - Groman-Lupa S
AU  - Jiménez-Martínez MC
PY  - 2023
JO  - Frontiers in ophthalmology
DO  - 10.3389/fopht.2023.1023782
UR  - https://doi.org/10.3389/fopht.2023.1023782
ER  - 

APA

M, C., S, G., & MC, J. (2023). MicroRNAs as potential biomarkers and therapeutic targets in age-related macular degeneration.. Frontiers in ophthalmology. https://doi.org/10.3389/fopht.2023.1023782

Source records